Share
Embolization Particle Market: By Product Type (Radioembolization Spheres, Drug Eluting Beads, Microspheres, PVA Particles & Gelfoam Particles, Others), By Application (Oncology, Peripheral Vascular Disease, Urology, Neurology, Others), By End User (Ambulatory Centers, Hospitals, Clinics) And Region - Global Analysis of Market Size, Share & Trends For 2021-2022 And Forecasts To 2032
[170+ Pages Research Report] Embolization Particle Market to surpass USD 8 billion by 2032 from USD 2.13 billion in 2021 at a CAGR of 12.7% throughout the forecast period 2022-32.
Embolization is a minimal invasive procedure where an embolus is injected to cease bleeding or to terminate blood supply to tumor for it to shrink in order to remove. Embolization is helpful in radiology procedures, to treat hemorrhages, several cancerous tumors & management of malignant. For this process, interventional radiologist uses image guidance to insert the catheter into blood vessel to terminate blood supply. Embolization is an alternative for tumors patients where surgery can’t be performed. It can be used for tumors that are generally greater than 5 cm thickness & cannot be separated by ablation. This procedure involves the initiation of emboli for occluding the blood vessels selectively.
Embolization Particle market is expected to project a CAGR of 12.7% during the forecast period
Embolization Particle market is expected to exceed beyond USD 8.0 billion by 2032 from USD 2.13 billion in 2021, growing at a CAGR of 12.7% during the forecast period, 2022-2032. Embolization particles are vital ingredients used to treat malignancies and the rising prevalence of cancer has aided in the growth of the embolization particle market. The increasing burden of cancer in several countries is expected to boost the growth of the market. The increasing expenditure of government to improve the pharmaceutical Research & Development is estimated to boost the growth of the Embolization Particle market.
Peripheral Vascular Disease segment is expected to grow with a higher CAGR during 2022-32
Embolization Particle market is classified based on Application into Oncology, Peripheral Vascular Disease, Urology, Neurology, Others. Peripheral Vascular Disease segment dominated the market in 2021 and is also expected to dominate in the forecast period owing to the rising prevalence of cancers and strong expansion of the oncology sector which is expected to drive the market growth in the forecast period. Embolization Particles are the key products used in malignancies treatment and the increasing awareness about embolization procedures is expected to boost the growth of Embolization Particle market.
Radioembolization Spheres segment is expected to grow with a higher CAGR during 2022-32
Embolization Particle market is classified based on the Product Type into Radioembolization Spheres, Drug Eluting Beads, Microspheres, PVA Particles & Gelfoam Particles, Others. Radioembolization Spheres segment is expected to dominate the Embolization Particle market as the embolization Particles are used in the treatment of cancer which are of major importance in the growth of the market.
Rising Occurrence of Cancer is Expected to Boost the Growth of the Market
The occurrence of cancers like prostrate, liver, bowel, breast, lung cancers has increased and the necessity of embolization particles has raised which created a growth opportunity for the market. The people being affected with various types of cancers is increasing and the proliferation of cancerous cells is rising which is creating demand for the growth of the Embolization Particle market.
Increasing Advancements in Technology is Expected to Drive the Market Growth
The key market players are focusing on implementing advancements in technology to innovate various novel products which has a scope of improvement and increased efficiency that will assist in the growth of the market. New therapies are emerging as an alternative option to the traditional therapies and are expected to boost the growth of the Embolization Particle market.
Stringent Regulations for Approval of Embolization Particles is Expected to Restrain the Market Growth
The Embolization Particle Market expansion would be hindered due to the presence of a smaller number of labs related to interventional neuroradiologists and neuroradiology (INR). The stringent regulations for the approval of embolization particle may also restrain the growth of the global embolization particle market. The deficiency of presence of skilled professionals may hamper the growth of the global embolization particle market.
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
Embolization Particle market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America dominated the market with the largest share in 2021 owing to the large expansion of healthcare system, the presence of strong economic condition in the region and rising focus on modernizing of the technology by research institutions. The Asia Pacific market is expected to dominate the Embolization Particle market in the forecast period owing to the availability of skilled healthcare professionals, rising patient population, increasing medical tourism and increasing government initiatives for enhancing healthcare facilities which is expected to boost the growth of the market in this region.
Covid-19 has badly affected the economies across the world. Many countries imposed nationwide lockdowns, travel bans, and social distancing norms to control the negative effects of the coronavirus. Due to this, many industries and businesses suffered huge loss but healthcare industry had growth during the pandemic. Increased acceptance of telehealth, initiatives by government for COVID-19 vaccine development, & demand for advanced diagnostics and healthcare products have boosted the growth of the Embolization Particle Market during the pandemic period.
Embolization Particle Market is further segmented by region into:
Embolization Particle Market Segments:
|
REPORT ATTRIBUTE |
DETAILS |
|
Market size value in 2021 |
USD 2.13 billion |
|
Revenue forecast in 2032 |
USD 8 billion |
|
Growth Rate |
CAGR of 12.7% from 2022 to 2032 |
|
Base year for estimation |
2021 |
|
Quantitative units |
Revenue in USD billion and CAGR from 2022 to 2032 |
|
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
|
Segments covered |
Product Type, Application, End-User, and Region |
|
Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
|
Key companies profiled |
Merit Medical, Boston Scientific Corporation, Pfizer, Edward Lifesciences, Sirtex Medical, HENGRUI Medical, Cook Medical, Johnson & Johnson, BTG Medical, Terumo Corporation, Interface Biomaterials B.V., Abbott Laboratories and Other Prominent Players |
Embolization Particle market size was estimated at USD 2.13 billion in 2021 and is expected to reach USD 8 billion in 2032.
Embolization is a minimal invasive procedure where an embolus is injected to cease bleeding or to terminate blood supply to tumor for it to shrink in order to remove. Embolization is helpful in radiology procedures, to treat hemorrhages, several cancerous tumors & management of malignant. This procedure involves the initiation of emboli for occluding the blood vessels selectively.
Peripheral Vascular Disease and Radioembolization Spheres segment accounted for the largest Embolization Particle market share.
Key players: Merit Medical, Boston Scientific Corporation, Pfizer, Edward Lifesciences, Sirtex Medical, HENGRUI Medical, Cook Medical, Johnson & Johnson, BTG Medical, Terumo Corporation, Interface Biomaterials B.V., Abbott Laboratories and Other Prominent Players are the key players in the Embolization Particle market.
Rising Occurrence of Cancer and Increasing Advancements in Technology are the factors driving the Embolization Particle market.
Select License Type
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT
Working with Fatpos Global, allowed us to take advantage of their knowledge and easy approach, allowing us to collect important data utilizing a variety of techniques. The results were clearly presented and explained, and FG responded to our questions with speed and expertise.
|
Swiss-based global building materials manufacturer |
The analyses and presentations Fatpos Global have produced for us have been of a very high caliber and have allowed us to proactively improve our customer relationship management. They have also done so while maintaining complete anonymity. Without any doubt, we suggest Fatpos Global to you.
|
|
Tech-powered construction company |
We appreciate the team’s punctuality, flexibility in terms of report modification, post report purchase support and pleasant reaction all around. Overall, my experience with this company was nothing but positive, and I couldn't be more grateful for their excellent service. Thank you for all that you do!
|
|
American global management consulting firm |
We are able to concentrate on the topics and implications that are most important to our clients thanks to the adaptability and responsiveness of the team at Fatpos Global. We would highly recommend this company to anyone in need of their services, and I will certainly be using them again in the future.
|
|
Headquartered in Zug, Switzerland, leading supplier of medical and surgical instrument |
To better study our client demographics, develop the ideal product-price architecture, and enhance our target marketing initiatives, we hired Fatpos Global. Every component of the project was completed, and we are very happy with the useful insights and actionable results.
|
|
Kosovan company, A leading organic fertilizers producer |
Thank you for your team's generous assistance, The final report was delivered to me, and I find it to be really helpful. Also, you may be sure that I will get in touch with you if I ever require fresh materials for market research. Gratitude once more.
|
|
German specialty chemicals company based in Cologne, Germany |
